In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Previews, March 2013

Executive Summary

This Month's Profile Group: Nanomedicine: Will It Get Big?, features profiles of Blend Therapeutics, Kala Pharmaceuticals, Qualiber, and Uroboros Technologies. Plus these Start-Ups Across Health Care: Ceterix Orthopaedics, Flux Medical, Neuros Medical, and Tunitas Therapeutics.

You may also be interested in...



Neuros Medical Inc.

Neuros Medical Inc.’s Altius is an implantable device that transmits a high-frequency electrical signal to a targeted nerve in the stump of a patient experiencing chronic pain stemming from a major limb amputation. Blocking the nerve activity eliminates the pain.

Ceterix Orthopaedics Inc.

The meniscal suture passer from Ceterix Orthopaedics Inc. is a handheld surgical instrument that due to its small size and design facilitates meniscus repair. Because it leaves the cushion of the meniscus intact, the company believes its device will help patients avoid the arthritic changes that frequently accompany meniscus removal.

Flux Medical NV

Traditional ablation for treating atrial fibrillation involves disconnecting the electrical pathway that causes the abnormal rhythm, and the procedure can take anywhere from two to four hours, thus limiting the number of cases a cath lab can handle each day. The self-expanding pulmonary vein implant in development at Flux Medical NV is easy to insert inside the vein and should make the procedure much shorter, allowing a cath lab to schedule up to six to eight cases a day.

Topics

Related Companies

UsernamePublicRestriction

Register

IV004014

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel